Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Synucleinopathies
Indianapolis, Indiana
Synucleinopathies Clinical Trials in Indianapolis, Indiana
1 recruiting
Indianapolis, Indiana
Showing
1–1
of
1
trials
Recruiting
Phase 2
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Cognitive Dysfunction
Lewy Body Disease
Amyloid
+1 more
Eli Lilly and Company
350 enrolled
72 locations
NCT07589595
Feedback